These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 29199701)
1. Demographic, clinical, biochemical, radiological and etiological characteristics of malignant pleural effusions from Eastern India. Saha K; Maikap MK; Maji A; Moitra M; Jash D Indian J Cancer; 2017; 54(1):257-261. PubMed ID: 29199701 [TBL] [Abstract][Full Text] [Related]
2. Investigating unilateral pleural effusions: the role of cytology. Arnold DT; De Fonseka D; Perry S; Morley A; Harvey JE; Medford A; Brett M; Maskell NA Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30262573 [TBL] [Abstract][Full Text] [Related]
3. Molecular Alterations in Patients with Pulmonary Adenocarcinoma Presenting with Malignant Pleural Effusion at the First Diagnosis. Rodriguez EF; Shabihkhani M; Carter J; Maleki Z Acta Cytol; 2017; 61(3):214-222. PubMed ID: 28538219 [TBL] [Abstract][Full Text] [Related]
4. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters. Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381 [TBL] [Abstract][Full Text] [Related]
6. Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer. Wang J; Fu J; Shen Q; Zhang F; Wang Y; Wu LL J Clin Lab Anal; 2019 Sep; 33(7):e22943. PubMed ID: 31268191 [TBL] [Abstract][Full Text] [Related]
7. Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups. Tsim S; Paterson S; Cartwright D; Fong CJ; Alexander L; Kelly C; Holme J; Evison M; Blyth KG Lung Cancer; 2019 Jul; 133():123-129. PubMed ID: 31200818 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis. Feng M; Zhu J; Liang L; Zeng N; Wu Y; Wan C; Shen Y; Wen F Int J Clin Oncol; 2017 Apr; 22(2):283-290. PubMed ID: 27990560 [TBL] [Abstract][Full Text] [Related]
10. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. Ylagan LR; Zhai J Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333 [TBL] [Abstract][Full Text] [Related]
11. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity. Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion. Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464 [TBL] [Abstract][Full Text] [Related]
13. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion. Chierakul N; Kanitsap A; Chaiprasert A; Viriyataveekul R Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604 [TBL] [Abstract][Full Text] [Related]
14. Central lung adenocarcinoma in a young male mimicking pneumonia with nonrecurrent polyserous effusions of negative cytology: A case report. Aljuba AA; Shawer BM; Aljuneidi RM; Halman S; Jobran AWM; Abdulrazzak M; Al Fallah O; Al Jebrini NEM; Bakri IA; Abu Asbeh Y Medicine (Baltimore); 2024 Aug; 103(31):e39189. PubMed ID: 39093786 [TBL] [Abstract][Full Text] [Related]
15. Clinical Profile of Patients Presenting with Malignant Pleural Effusion to a Tertiary Health Care Centre. Gadewad N; Deokar K; Ghorpade S J Assoc Physicians India; 2017 Aug; 65(8):28-31. PubMed ID: 28799302 [TBL] [Abstract][Full Text] [Related]
16. Pleural fluid cytology samples in cases of suspected lung cancer: An experience from a tertiary care centre. Kaur G; Nijhawan R; Gupta N; Singh N; Rajwanshi A Diagn Cytopathol; 2017 Mar; 45(3):195-201. PubMed ID: 28112486 [TBL] [Abstract][Full Text] [Related]
17. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion. Han HS; Yun J; Lim SN; Han JH; Lee KH; Kim ST; Kang MH; Son SM; Lee YM; Choi SY; Yun SJ; Kim WJ; Lee OJ Int J Cancer; 2013 Aug; 133(3):645-52. PubMed ID: 23354517 [TBL] [Abstract][Full Text] [Related]
18. Comparative study of visceral and parietal pleural biopsy in the etiological diagnosis of pleural diseases. Jain NK; Guhan AR; Joshi N; Dixit R; Singh V; Meena RP J Assoc Physicians India; 2000 Aug; 48(8):776-80. PubMed ID: 11273468 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion. Basso SMM; Del Conte A; Zuccon U; Sulfaro SC; Fanti G; Maffeis F; Ubiali P; Ermani M; Lumachi F Anticancer Res; 2020 Oct; 40(10):5877-5881. PubMed ID: 32988918 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis. Miyoshi S; Sasada S; Izumo T; Matsumoto Y; Tsuchida T PLoS One; 2016; 11(11):e0167186. PubMed ID: 27880851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]